多室限制谱成像评估慢性乙型肝炎患者肝纤维化
前瞻性纳入80例慢性乙型肝炎患者和19例健康对照,行3.0 T MRI多b值扩散加权成像,比较4室限制谱成像模型与常规ADC对肝纤维化分期的诊断效能。C4分数随纤维化加重而下降,区分F0-F2与F3-F4的AUC为0.774,高于ADC的0.654。
要点
- 4室限制谱成像模型经贝叶斯信息准则筛选为最优模型。
- C4分数与纤维化分期呈负相关(r=-0.493),相关性强于ADC(r=-0.324)。
- C4区分F0-F2与F3-F4的AUC为0.774,特异度75.0%,均优于ADC。
核心结论
- 4室限制谱成像模型是有前景的无创肝纤维化分期工具,C4分数作为反映灌注下降的敏感生物标志物,分期准确度优于ADC。
研究设计与样本
- 前瞻性研究纳入80例慢性乙型肝炎患者和19例健康对照(METAVIR F0-F4),采用3.0 T MRI多b值扩散加权成像(b=0-2000 s/mm2),拟合2至5室四种限制谱成像模型并以贝叶斯信息准则(ΔBIC)选择最优模型。
关键影像表现/征象
- C4(快速伪扩散分数)随纤维化加重显著下降(P=.004)。
- C4与纤维化分期的负相关性强于ADC(r=-0.493 vs -0.324,P<.001)。
- 限制谱成像可逐体素定量纤维化,相比ROI平均扩散技术可能有利于详细空间分析。
诊断标准与关键数值
- 区分F0-F2与F3-F4:C4的AUC为0.774(95%CI:0.679-0.852),ADC的AUC为0.654(95%CI:0.552-0.747),P=.033。
- 区分F0-F2与F3-F4:C4特异度75.0%,ADC特异度44.6%。
- 区分F0-F1与F2-F4:C4的AUC为0.814,ADC的AUC为0.686(P=.020)。
临床应用与阅片要点
- 4室限制谱成像模型经贝叶斯信息准则选择为最优模型,可用于肝纤维化无创分期评估。
- C4分数反映灌注下降,可作为纤维化进展的敏感生物标志物,其分期准确度优于ADC。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To optimize multi-compartment restriction spectrum imaging (RSI) models and validate their diagnostic performance for non-invasive staging of liver fibrosis in chronic hepatitis B (CHB), compared to conventional apparent diffusion coefficient (ADC).
METHODS: This prospective study enrolled 80 CHB patients and 19 healthy controls (METAVIR F0-F4). All underwent 3.0 T MRI with multi-shell diffusion-weighted imaging (b = 0-2000 s/mm2). Four RSI models (2-5 compartments) were fitted; the optimal model was selected using Bayesian Information Criterion (ΔBIC). Conventional ADC and RSI compartmental fractions were compared across fibrosis stages. Diagnostic performance was assessed via ROC analysis.
RESULTS: The 4-compartment RSI model demonstrated the lowest ΔBIC. Compartment C4 (fast pseudo-diffusion fraction) decreased significantly with fibrosis (P = .004), showing a stronger inverse correlation with fibrosis stage than ADC (r = -0.493 vs -0.324, P < .001). For distinguishing F0-F2 vs F3-F4, C4 achieved: Higher AUC than ADC (0.774 [95% CI: 0.679-0.852] vs 0.654 [0.552-0.747]; P = .033); Superior specificity (75.0% vs 44.6%). For F0-F1 vs F2-F4, C4's AUC was 0.814 vs ADC's 0.686 (P = .020).
CONCLUSION: The 4-compartment RSI model is a promising non-invasive tool for liver fibrosis staging. By resolving distinct diffusion and perfusion compartments, RSI overcomes key limitations of conventional DWI, with the C4 fraction (thought to reflect perfusion decline) serving as a sensitive biomarker for fibrosis progression and outperforming ADC in staging accuracy.
ADVANCES IN KNOWLEDGE: (1) First application of RSI to liver fibrosis staging. (2) C4 fraction is a sensitive biomarker for perfusion loss in fibrosis. (3) RSI enables voxel-wise quantification of fibrosis, offering a potential advantage over ROI-averaged diffusion techniques for detailed spatial analysis.
引用
- Zhang J, Lu Z, Yang K, et al. Evaluating liver fibrosis in chronic hepatitis B patients using multi-compartment restriction spectrum imaging. Br J Radiol. 2026. PMID: 41915030. doi:10.1093/bjr/tqag072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。